Key result
Resynchronisation acutely increases peak VO2 by ~1.6 ml/kg/min compared to native activation in heart failure.
Why the study?
The acute effect of cardiac resynchronisation therapy on exercise performance and the underlying mechanism involving total isovolumic time in heart failure patients were not well defined.
Does resynchronisation therapy acutely improve peak oxygen uptake and shorten total isovolumic time compared to native activation in heart failure patients?
RCT (n=22)
random order
Does resynchronisation therapy acutely improve peak oxygen uptake and shorten total isovolumic time compared to native activation in heart failure patients?
Mean Difference: 1.6
p-value: p=<0.001
Cardiac resynchronization therapy acutely improves peak oxygen uptake in heart failure patients, an effect that is best predicted by a long total isovolumic time during peak stress under native activation.
Acute resynchronisation may enhance exercise capacity in selected HF patients; leaves open whether stress isovolumic time predicts chronic CRT response.
BACKGROUND: Cardiac resynchronisation therapy improves peak oxygen uptake (peak VO(2)) 3-9 months after device implantation. In chronic heart failure, total isovolumic time (t-IVT) is a major determinant of peak VO(2) and of cardiac output at peak dobutamine stress. In selected patients, resynchronisation can instantaneously shorten t-IVT. We sought to determine the acute effect of resynchronisation on exercise performance and determine, with pharmacological stress echocardiography, the mechanism underlying this effect. METHODS AND RESULTS: Twenty-two patients with resynchronisation were studied within 3 months after device implantation. On a single study day, sequential cardiopulmonary exercise tests were performed during native activation (left bundle branch block) and resynchronisation (atrio-biventricular pacing) in random order. Total-IVT and cardiac output (at rest and peak dobutamine stress) were then measured in each activation mode. Resynchronisation acutely increased peak VO(2) by 1.6 (SD 1.5) ml/kg/min (p<0.001) and shortened peak stress t-IVT by 10 (SD 7) s/min (p<0.001), with the effects in individual patients showing a correlation (r = -0.46, p<0.05). Amongst all measurements during native activation, the best predictor of gain in peak VO(2) from resynchronisation was peak stress t-IVT (r = 0.71, p<0.001) with every increment of 5 s/min of peak stress t-IVT during native activation predicting an 8% gain in peak VO(2). No conventional measures during native activation at rest or on stress (including QRS duration, Tei index, tissue Doppler intraventricular delay, and resting t-IVT) added significant additional information. CONCLUSIONS: In eligible patients, resynchronisation can acutely augment peak VO(2), possibly through a mechanism of t-IVT shortening. Under native activation, long t-IVT during peak stress is the single best predictor of acute resynchronisation-mediated increment in peak VO(2).
No takes yet. Share an insight, caveat, or question.
Salukhe et al. (2006) conducted an RCT in heart failure (n=22). Resynchronisation (atrio-biventricular pacing) vs. Native activation (left bundle branch block) was evaluated on peak oxygen uptake (peak VO2) (MD 1.6 ml/kg/min, p=<0.001). Resynchronisation acutely increased peak VO2 by 1.6 ml/kg/min (p<0.001) and shortened peak stress total isovolumic time by 10 s/min (p<0.001) compared to native activation in heart failure patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: